1.Clinical application of therapeutic plasma exchange.
Dong Seok JEON ; Bok Cheol HWANG ; Hyo Jin CHUN ; Jay Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1991;2(2):175-181
No abstract available.
Plasma Exchange*
;
Plasma*
2.Analysis of blood transfused for past five years at Dongsan hospital.
Soo Jin PARK ; Dong Seok JEON ; Hyo Jin CHUN ; Jae Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1993;4(2):181-186
No abstract available.
3.Analysis of blood transfused for past five years at Dongsan hospital.
Soo Jin PARK ; Dong Seok JEON ; Hyo Jin CHUN ; Jae Ryong KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1993;4(2):181-186
No abstract available.
4.Changes of fibrinogen and coagulation factor NIII in cryoprecipitate according to storage temperature and time after thawing.
Young Jae KIM ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Pyong KIM ; Dal Hyo SONG
Korean Journal of Clinical Pathology 1992;12(3):395-400
No abstract available.
Blood Coagulation Factors*
;
Fibrinogen*
5.Changes of fibrinogen and coagulation factor NIII in cryoprecipitate according to storage temperature and time after thawing.
Young Jae KIM ; Hyo Jin CHUN ; Dong Seok JEON ; Jae Pyong KIM ; Dal Hyo SONG
Korean Journal of Clinical Pathology 1992;12(3):395-400
No abstract available.
Blood Coagulation Factors*
;
Fibrinogen*
6.Changes of Plasma Components by the Plasma Exchange.
Hyo Jin CHUN ; Jae Ryong KIM ; Gyoung Yim HA ; Dong Seok JEON ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1995;6(2):141-154
Therapeutic plasma exchange is used in almost every condition in which there is a plasma factor thought possibly to the etiology or pathogenesis of a disease or one of its manifestations. In order to evaluate plasma exchange using fresh frozen plasma as replacement solution, eighty four therapeutic plasma exchanges were carried out in eighteen patients. In standardized procedures, 1.5 times the calculated plasma volume was replaced with a Hartman's solution and fresh frozen plasma. Anticoagulation was achieved using a whole venous blood to 2.5% trisodium citrate in the ratio of 10 to 1. Total calcium, phosphorus, glucose, urea nitrogen, creatinine, bilirubin, alkaline phosphatase, amylase, creatine kinase, IgG, C3, total white and red blood cell count, hemoglobin, and differential count were not significantly affected by the procedure. In contrast, serum cholesterol, total protein, albumin, aspartate aminotransferase, alanine aminotransferase, ionized calcium, IgM, C4 and platelet were significantly decreased by the plasma exchange. All these measurements had returned to the first pre-exchange level within 24 hours, while the C4 and platelet count took between 24 and 72 hours, and the IgM level, between 72 hours and 1 week. These data indicated that in an isovolemic plasma exchange there was a transient but rapidly reversible effect on all the components studied, with C4 and platelet count, returning more slowly to pre-exchange level than the others, and IgM levels responding the slowest. In summary, plasma exchanges using fresh frozen plasma as replacement solution were assumed to be not significantly affected the function of various organs.
Alanine Transaminase
;
Alkaline Phosphatase
;
Amylases
;
Aspartate Aminotransferases
;
Bilirubin
;
Blood Platelets
;
Calcium
;
Cholesterol
;
Citric Acid
;
Creatine Kinase
;
Creatinine
;
Erythrocyte Count
;
Glucose
;
Humans
;
Immunoglobulin G
;
Immunoglobulin M
;
Nitrogen
;
Phosphorus
;
Plasma Exchange*
;
Plasma Volume
;
Plasma*
;
Platelet Count
;
Urea
7.In vitro platelet assessment of the stored CPDA-1 platelet concentrates.
Kan Hee HAN ; Jang Soo SUN ; Nam Kyung KIM ; Jay Sik KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1992;3(2):143-150
No abstract available.
Blood Platelets*
8.Bacterial growth in artificially contaminated packed red cells following room temperature exposure.
Bo Chan JEONG ; Chae Hoon LEE ; Kyung Dong KIM ; Chung Sook KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1993;4(1):89-95
No abstract available.
9.Regression Analysis on Physical Status of Korean Middle and High School Boys.
Korean Journal of Preventive Medicine 1974;7(2):299-304
No abstract available.
Humans
;
Regression Analysis*
10.Comparative Study of Anti-HCV by New HCV EIA, Immunoblotting and RT-PCR in Korean Blood Donors.
Sang Jin EUN ; Jang Soo SUH ; Won Kil LEE ; Jay Sik KIM ; In Soo KIM ; Jong Gyu KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1994;5(1):9-16
A newly developed third generation enzyme immunoassay(Lucky HCD 3.0 EIA) for hepatitis C virus(HCV) antibodies was added with the envelope(E1E2)/NS4 fusion proteins and expanded NS5 proteins as well as the core/NS3 fusion proteins. Authors evaluated the HCD 3.0 EIA with the previously available second generation EIA(HCD 2.0) in 10,435 Red Cross blood donors. Among 10,435 donors who were screened for the presence of HCV antibodies by HCD 2.0 assay, 22(0.21%) sera were repeatedly reactive. All of these sera were tested for further testing. Only 13 of all tested sera were reactive by HCD 3.0 EIA, and nine sera were not reactive. Nine of 13 HCD 3.0 positive sera were reactive by recombinant immunoblot assay(Lucky-Confirm). Also seven of these 13 sera had detectable HCV genomic RNA by reverse transcriptase-polymerase chain reaction(RT-PCR). None of nine HCD 3.0 negative samples had detectable immunoblot assay and HCV genomic RNA. It is concluded that the new HCV EIA can decrease a significant false positivity of second generation EIA in a blood donor population. This new assay correlates well with detection of HCV-RNA by RT-PCR and identifies donors who are truly infected.
Antibodies
;
Blood Donors*
;
Hepatitis C
;
Hepatitis C Antibodies
;
Humans
;
Immunoblotting*
;
Red Cross
;
RNA
;
Tissue Donors